Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Hengxinyuan Pharmaceutical is a specialized pharmaceutical company based in Wuhan, China, focusing on the research, development, and production of Active Pharmaceutical Ingredients (APIs) and high-end chemical intermediates. The company is particularly known for its expertise in the synthesis of neurological agents, including tianeptine derivatives and various nootropic compounds. They operate modern manufacturing facilities and provide custom synthesis services to the global pharmaceutical and life sciences industries. Their business model centers on the large-scale supply of high-purity chemicals for research and commercial formulation. The company maintains a strong presence in the international export market for specialty neurological APIs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Hengxinyuan Pharmaceutical.